Security key
44486Q103
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 55,385,756
- Total 13F value
- $53,205,316
- Share change
- +8,585,745
- Put/Call ratio
- 57%
- SEC-reported price per share
- $0.96
- Number of holders
- 146
- Value change
- +$7,815,206
- Number of buys
- 76
- Number of sells
- 50
- Shares outstanding
- 272,828,667
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
146
Top holders
10
HUMA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2026
Humacyte, Inc. SEC filings
Humacyte, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 44486Q103
Recent filing periods:
Ownership snapshot
Top reported holders of HUMA - Humacyte, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ayabudge LLC
Disclosed value leader
FRESENIUS MEDICAL CARE HO...
Comparable rows
0/15
Latest evidence
30 Sep 2025
3/4/5
13F
Highest disclosed value: $21,792,154
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ has the largest disclosed position value at $21.79M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FRESENIUS MEDICAL CARE HOLDINGS INC /NY/'s linked filing trail.
Disclosed position value
Top 5
Ayabudge LLC
$9.75M
FRESENIUS MEDICAL CARE HOLDINGS I...
$21.79M
BlackRock, Inc.
$17.23M
VANGUARD GROUP INC
$13.08M
GEODE CAPITAL MANAGEMENT, LLC
$5.39M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ayabudge LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$9,747,457
8,191,140 shares
|
— | 17 Aug 2023 |
| FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ |
3/4/5
Former 10% Shareholder
|
—
denominator unverified
|
$21,792,154
18,312,735 shares
|
— | 26 Aug 2021 |
| BlackRock, Inc. |
13F
Company
|
—
denominator unverified
|
$17,229,123
9,901,795 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$13,084,896
7,520,055 shares
|
— | 30 Sep 2025 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$5,388,322
3,096,216 shares
|
— | 30 Sep 2025 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$4,189,995
2,408,043 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
146
Shares
55,385,756
Rows available
146
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
138
Q4 2025 holders
146
Holder diff
8
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend